Analytical methods for the detection of clenbuterol

Bioanalysis

Volumn 1, Issue 2, 2009, Pages 437-450

  Parr, Maria K ^a   Opfermann, Georg ^a   Schäänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; BRONCHODILATING AGENT; CLENBUTEROL;

ANIMAL; BLOOD; CATTLE; CHROMATOGRAPHY; ENVIRONMENT; HORSE; HUMAN; INFRARED SPECTROPHOTOMETRY; MASS SPECTROMETRY; METABOLISM; REVIEW; URINE;

ANABOLIC AGENTS; ANIMALS; BRONCHODILATOR AGENTS; CATTLE; CHROMATOGRAPHY; CLENBUTEROL; ENVIRONMENT; HORSES; HUMANS; MASS SPECTROMETRY; SPECTROPHOTOMETRY, INFRARED;

EID: 78349312105     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.29     Document Type: Review

References (133)

1. British Thoracic Society. British Guideline on the management of asthma. Thorax 63, iv1-121 (2008)
2. EEC, Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of b-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC. (1996).
3. EEC, Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. (1990).
4. ® Syrup, prescribing information. Boehringer Ingelheim Vetmedica, Inc., MO, USA (2001).
5. Rehfeldt C, Weikard R, Reichel K. [The effect of the b-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats]. Arch. Tierernahr. 45, 333-344 (1994).
6. Maltin CA, Delday MI, Hay SM, Smith FG, Lobley GE, Reeds PJ. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle. Biosci. Rep. 7, 143-149 (1987).
7. Brockway JM, MacRae JC, Williams PE. Side effects of clenbuterol as a repartitioning agent. Vet. Rec. 120, 381-383 (1987).
8. Drug Enforcement Administration. Drugs and chemicals of concern-clenbuterol. US Department of Justice (2007).
9. Parr MK, Köhler K, Geyer H, Guddat S, Schänzer W. Clenbuterol marketed as dietary supplement. Biomed. Chromatogr. 22, 298-300 (2008).
10. Geyer H, Parr MK, Köhler K, Mareck U, Schänzer W, Thevis M. Nutritional supplements cross-contaminated and faked with doping substances. J. Mass Spectrom. 43, 892-902 (2008).
11. Meyer HH. The illegal practice and resulting risks versus the controlled use of licensed drugs: views on the present situation in Germany. Ann. Rech. Vet. 22, 299-304 (1991).
12. Elliott CT, Shortt HD, Kennedy DG, McCaughey WJ. Monitoring for clenbuterol abuse in N. Ireland 1989-1994. Vet. Q. 18, 41-44 (1996).
13. Kuiper HA, Noordam MY, van Dooren-Flipsen MM, Schilt R, Roos AH. Illegal use of b-adrenergic agonists: European community. J. Anim. Sci. 76, 195-207 (1998).
14. Mitchell GA, Dunnavan G. Illegal use of b-adrenergic agonists in the United States. J. Anim. Sci. 76, 208-211 (1998).
15. Barbosa J, Cruz C, Martins J et al. Food poisoning by clenbuterol in Portugal. Food Addit. Contam. 22, 563-566 (2005).
16. Brambilla G, Cenci T, Franconi, F et al. Clinical and pharmacological profle in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol. Lett. 114, 47-53 (2000).
17. Sporano V, Grasso L, Esposito M, Oliviero G, Brambilla G, Loizzo A. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet. Hum. Toxicol. 40, 141-143 (1998).
18. Brambilla G, Loizzo A, Fontana L, Strozzi M, Guarino A, Soprano V. Food poisoning following consumption of clenbuterol-treated veal in Italy. JAMA 278, 635 (1997).
19. Pulce C, Lamaison D, Keck G, Bostvironnois C, Nicolas J, Descotes J. Collective human food poisonings by clenbuterol residues in veal liver. Vet. Hum. Toxicol. 33, 480-481 (1991).
20. Salleras L, Dominguez A, Mata E, Taberner JL, Moro I, Salva P. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep. 110, 338-342 (1995).
21. Martinez-Navarro JF. Food poisoning related to consumption of illicit b-agonist in liver. Lancet 336, 1311 (1990).
22. Smith DJ. Stereochemical composition of clenbuterol residues in edible tissues of swine. J. Agric. Food Chem. 48, 6036-6043 (2000).
23. Salquebre G, Bresson M, Villain M, Cirimele V, Kintz P. Clenbuterol determination in calf hair by UPLC-MS-MS: case report of a fraudulent use for cattle growth. J. Anal. Toxicol. 31, 114-118 (2007).
24. Kintz P, Dumestre-Toulet V, Jamey C, Cirimele V, Ludes B. Doping control for b-adrenergic compounds through hair analysis. J. Forensic Sci. 45, 170-174 (2000).
25. Internationale FE. Equine Anti-Doping and Medication Control Rules. 1-23 (2006).
26. Dumestre-Toulet V, Cirimele V, Ludes B, Gromb S, Kintz P. Hair analysis of seven bodybuilders for anabolic steroids, ephedrine, and clenbuterol. J. Forensic Sci. 47, 211-214 (2002).
27. Machnik M, Geyer H, Horning S, Breidbach A, Delahaut P, Schänzer W. Long-term detection of clenbuterol in human scalp hair by gas chromatography-high-resolution mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 723, 147-155 (1999).
28. Wingert WE, Mundy LA, Nelson L, Wong SC, Curtis J. Detection of clenbuterol in heroin users in twelve postmortem cases at the Philadelphia medical examiner's offce. J. Anal. Toxicol. 32, 522-528 (2008).
29. Bilkoo P, Thomas J, Riddle CD, Kagaoan G. Clenbuterol toxicity: an emerging epidemic. A case report and review. Conn. Med. 71, 89-91 (2007).
30. Werder G, Arora G, Frisch A, Aslam S, Imani F, Missri J. Clenbuterol-contaminated heroin: cardiovascular and metabolic effects. A case series and review. Conn. Med. 70, 5-11 (2006).
31. Gleixner A, Meyer HH, Vos A, Aylan O. Clenbuterol as a marker in baits for oral vaccination of dogs against rabies. Vet. Rec. 143, 65-68 (1998).
32. Rabiet M, Togola A, Brissaud F, Seidel JL, Budzinski H, Elbaz-Poulichet F. Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ. Sci. Technol. 40, 5282-5258 (2006).
33. Bres J, Clauzel AM, Pistre MC, Rachmat H, Bressolle F. [Metabolism of b-adrenergic substances. Therapeutic implications]. Bull. Eur. Physiopathol. Respir. 21, 19S-34S (1985).
34. Council of Europe. Clenbuterol hydrochloride. In: European Pharmacopoeia. Deutscher Apotheker Verlag, Stuttgart, Germany, 1805-1806 (2008).
35. Clarke's Analysis of Drugs and Poisons (3rd Edition). Moffat AC, Osselton MD, Widdop B (Eds). Pharmaceutical Press, London, UK (2004).
36. Haughey SA, Baxter GA, Elliott CT, Persson B, Jonson C, Bjurling P. Determination of clenbuterol residues in bovine urine by optical immunobiosensor assay. J. AOAC Int. 84, 1025-1030 (2001).
37. ®) in the horse. Journal of Veterinary Medicine Series a-Zentralblatt Fur Veterinarmedizin Reihe a-Physiology Pathology Clinical Medicine 42, 209-219 (1995).
38. Xu T, Wang BM, Sheng W, Li QX, Shao XL, Li J. Application of an enzyme-linked immunosorbent assay for the detection of clenbuterol residues in swine urine and feeds. J. Environ. Sci. Health B 42, 173-177 (2007).
39. Polettini A, Segura J, Gonzalez G, de la Torre X, Montagna M. Clenbuterol and b-adrenergic drugs detected in hair of treated animals by ELISA. Clin. Chem. 41, 945-946 (1995).
40. Adam A, Gervais N, Panoyan A et al. Detection of clenbuterol residues in hair. Analyst 119, 2663-2666 (1994)
41. BIOO Scientifc Corp. b-agonist ELISA Test Kit Manual (2007).
42. Meyer HH, Rinke L, Dursch I. Residue screening for the b-agonists clenbuterol, salbutamol and cimaterol in urine using enzyme immunoassay and high-performance liquid chromatography. J. Chromatogr. 564, 551-556 (1991).
43. Roda A, Manetta AC, Piazza F, Simoni P, Lelli R. A rapid and sensitive 384-microtiter wells format chemiluminescent enzyme immunoassay for clenbuterol. Talanta 52, 311-318 (2000).
44. Meyer HH, Rinke LM. The pharmacokinetics and residues of clenbuterol in veal calves. J. Anim. Sci. 69, 4538-4544 (1991).
45. Li Z, Jian L, Wang H, Cui Y. Flow injection chemiluminescent determination of clenbuterol using GoldMag particles as carrier. Food Addit. Contam. 24, 21-25 (2007).
46. Peng Z, Bang-Ce Y. Small molecule microarrays for drug residue detection in foodstuffs. J. Agric. Food Chem. 54, 6978-6983 (2006).
47. Zou M, Gao H, Li J, Xu F, Wang L, Jiang J. Rapid determination of hazardous compounds in food based on a competitive fuorescence microsphere immunoassay. Anal. Biochem. 374, 318-324 (2008).
48. Johansson MA, Hellenas KE. Matrix effects in immunobiosensor determination of clenbuterol in urine and serum. Analyst 129, 438-442 (2004).
49. Lai W, Xu Y, Fung DY, Xiong Y. Development of a lateral-fow assay for rapid screening of the performance-enhancing sympathomimetic drug clenbuterol used in animal production; food safety assessments. Asia Pac. J. Clin. Nutr. 16(Suppl. 1), 106-110 (2007).
50. Zhang GP, Wang XN, Yang JF et al. Development of an immunochromatographic lateral fow test strip for detection of b-adrenergic agonist clenbuterol residues. J. Immunol. Methods 312, 27-33 (2006).
51. Danyi S, Degand G, Duez C, Granier B, Maghuin-Rogister G, Scippo ML. Solubilisation and binding characteristics of a recombinant b2-adrenergic receptor expressed in the membrane of Escherichia coli for the multianalyte detection of b-agonists and antagonists residues in food-producing animals. Anal. Chim. Acta 589, 159-165 (2007).
52. Engelmann MD, Hinz D, Wenclawiak BW. Solid-phase micro extraction (SPME) and headspace derivatization of clenbuterol followed by GC-FID and GC-SIMMS quantifcation. Anal. Bioanal. Chem. 375, 460-464 (2003).
53. Gallo P, Brambilla G, Neri B, Fiori M, Testa C, Serpe L. Purifcation of clenbuterol-like b2-agonist drugs of new generation from bovine urine and hair by alpha1-acid glycoprotein affnity chromatography and determination by gas chromatography-mass spectrometry. Anal. Chim. Acta 587, 67-74 (2007).
54. Henze MK, Opfermann G, Spahn-Langguth H, Schänzer W. Screening of b-2 agonists and confrmation of fenoterol, orciprenaline, reproterol and terbutaline with gas chromatography-mass spectrometry as tetrahydroisoquinoline derivatives. J. Chromatogr. B Biomed. Sci. Appl. 751, 93-105 (2001).
55. Damasceno L, Ventura R, Ortuno J, Segura J. Derivatization procedures for the detection of b(2)-agonists by gas chromatographic/mass spectrometric analysis. J. Mass Spectrom. 35, 1285-1294 (2000).
56. Damasceno L, Ventura R, Cardoso J, Segura J. Diagnostic evidence for the presence of b-agonists using two consecutive derivatization procedures and gas chromatography-mass spectrometric analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 780, 61-71 (2002).
57. Abukhalaf IK, von Deutsch DA, Parks BA et al. Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA. Biomed. Chromatogr. 14, 99-105 (2000).
58. Gonzalez-Gigosos P, Fente-Sampayo C, Franco-Abuin C, Cepeda-Saez A, Vazquez-Belda BI. Effects of frozen storage on the recovery of clenbuterol from urine samples for offcial control. Food Addit. Contam. 19, 1010-1014 (2002).
59. Seinsch I. Bestimmung der b-2-agonisten clenbuterol, isoxsuprin, salbutamol und cimaterol in plasma und urin des pferdes. Thesis: Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät. Universität Leipzig, Leipzig, Germany (1997).
60. Ventura R, Damasceno L, Farre M, Cardoso J, Segura J. Analytical methodology for the detection of b2-agonists in urine by gas chromatography-mass spectrometry for application in doping control. Analytica Chimica Acta 418, 79-92 (2000).
61. Harkins JD, Woods WE, Lehner AF, Fisher M, Tobin T. Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses. J. Vet. Pharmacol. Ther. 24, 7-14 (2001).
62. Polettini A, Groppi A, Ricossa MC, Montagna M. Gas chromatographic/ electron impact mass spectrometric selective confrmatory analysis of clenbuterol in human and bovine urine. Biol. Mass Spectrom. 22, 457-461 (1993).
63. Brunelli C, Bicchi C, Di Stilo A, Salomone A, Vincenti M. High-speed gas chromatography in doping control: fast-GC and fast-GC/MS determination of b-adrenoceptor ligands and diuretics. J. Sep. Sci. 29, 2765-2771 (2006).
64. Sigmund G, Horning S, Seinsch I, Schänzer W. Confrmation of clenbuterol-Reextraction with hydrochloric acid. In: Recent Advances in Doping Analysis. Mareck-Engelke U (Ed.). Sport und Buch Strauss, Köln, Germany 129-133 (1998).
65. Spisso BF, Lopes CC, Marques MA, Neto FR. Determination of b2-agonists in bovine urine: comparison of two extraction/clean-up procedures for high-resolution gas chromatography-mass spectrometry analysis. J. Anal. Toxicol. 24, 146-152 (2000).
66. Henze MK. Screening auf b2-sympathomimetika in der doping-analytik: entwicklung und erprobung eines gaschromatographisch massenspektrometrischen analyseverfahrens für human-urin. Thesis: Mathematisch- Naturwissenschaftlich-Technische Fakultät. Martin-Luther-Universität, Halle-Wittenberg, Germany (2001).
67. Amendola L, Colamonici C, Rossi F, Botre F. Determination of clenbuterol in human urine by GC-MS-MS-MS: confrmation analysis in antidoping control. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 773, 7-16 (2002).
68. Van Eenoo P, Delbeke FT, Deprez P. Detection of inhaled clenbuterol in horse urine by GC/MS2. Biomed. Chromatogr. 16, 475-481 (2002).
69. Pereira HM, Marques MA, Talhas IB, Aquino Neto FR. Analysis of androgenic steroids, b-2 agonists and other substances by GC-MS-ITD. In: Recent Advances in Doping Analysis. Schänzer W et al. (Eds). Sport und Buch Strauß, Köln, Germany, 259-263 (2003).
70. Anielski P. Langzeitnachweis anaboler steroidhormone. Thesis: Fakultät Mathematik und Naturwissenschaften. Technische Universität Dresden, Dresden, Germany 205 (2007).
71. Schlupp A, Anielski P, Thieme D, Muller RK, Meyer H, Ellendorff F. The b-agonist clenbuterol in mane and tail hair of horses. Equine Vet. J. 36, 118-122 (2004).
72. Blanchfower WJ, Hewitt SA, Cannavan A, Elliott C T, Kennedy DG. Detection of clenbuterol residues in bovine liver, muscle, retina and urine using gas chromatography/mass spectrometry. Biol. Mass Spectrom. 22, 326-330 (1993).
73. Guan F, Uboh CE, Soma LR et al. Quantifcation of clenbuterol in equine plasma, urine and tissue by liquid chromatography coupled on-line with quadrupole time-of-fight mass spectrometry. Rapid Commun. Mass Spectrom. 16, 1642-1651 (2002).
74. Bazylak G, Nagels LJ. Integrated acquisition of analytical and biopharmaceutical screening data for b-adrenergic-drugs employing diversifed macrocycle supported potentiometric detection in HPLC systems. Curr. Med. Chem. 9, 1547-1566 (2002).
75. Polettini A, Montagna M, Hogendoorn EA, Dijkman E, Vanzoonen P, Vanginkel LA. Applicability of coupled-column liquid-chromatography to the analysis of b-agonists in urine by direct sample injection.1. Development of a single-residue reversed-phase liquid-chromatography UV method for clenbuterol and selection of chromatographic conditions suitable for multi-residue analysis. J. Chromatogr. A 695, 19-31 (1995).
76. Wen Y, Wang Y, Feng YQ. Extraction of clenbuterol from urine using hydroxylated poly(glycidyl methacrylate-co-ethylene dimethacrylate) monolith microextraction followed by high-performance liquid chromatography determination. J. Sep. Sci. 30, 2874-2880 (2007).
77. Zhang Y, Zhang Z, Sun Y, Wei Y. Development of an analytical method for the determination of b2-agonist residues in animal tissues by high-performance liquid chromatography with on-line electrogenerated [Cu(HIO6)2]5-luminol chemiluminescence detection. J. Agric. Food Chem. 55, 4949-4956 (2007).
78. Thevis M, Opfermann G, Schänzer W. Liquid chromatography/ electrospray ionization tandem mass spectrometric screening and confrmation methods for b2-agonists in human or equine urine. J. Mass Spectrom. 38, 1197-1206 (2003).
79. Lau JH, Khoo CS, Murby JE. Determination of clenbuterol, salbutamol, and cimaterol in bovine retina by electrospray ionization-liquid chromatography-tandem mass spectrometry. J. AOAC Int. 87, 31-38 (2004).
80. Leung GN, Leung DK, Wan TS, Wong CH. High throughput screening of sub-ppb levels of basic drugs in equine plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1156, 271-279 (2007).
81. Shen S, Ouyang J, Baeyens WR, Delanghe JR, Yang Y. Determination of b2-agonists by ion chromatography with direct conductivity detection. J. Pharm. Biomed. Anal. 38, 166-172 (2005).
82. Yuen AH, Yacoub MH, Smolenski RT. Determination of clenbuterol concentration in human blood using liquid chromatography with electrospray/ion-trap tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19, 3603-3606 (2005).
83. Lehner AF, Harkins JD, Karpiesiuk W et al. Clenbuterol in the horse: confrmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. J. Anal. Toxicol. 25, 280-287 (2001).
84. Thevis M, Schebalkin T, Thomas A, Schänzer W. Quantifcation of clenbuterol in human plasma and urine by liquid chromatography-tandem mass spectrometry. Chromatographia 62, 435-439 (2005).
85. Chen Z, Zeng S, Yao T. Separation of b-receptor blockers and analogs by capillary liquid chromatography (CLC) and pressurized capillary electrochromatography (pCEC) using a vancomycin chiral stationary phase column. Pharmazie 62, 585-592 (2007).
86. Zhang D, Cheng M, Hyun MH, Xiong Z, Pan L, Li F. Enantiomeric separation of b2-agonists on macrocyclic antibiotic chiral stationary phases in high performance liquid chromatography. Pharmazie 62, 836-840 (2007).
87. Song Y, Wang D, Hu Y, Chen X, Jiao Y, Hou D. Direct separation and quantitative determination of clenbuterol enantiomers by high performance liquid chromatography using an amide type chiral stationary phase. J. Pharm. Biomed. Anal. 31, 311-319 (2003).
88. Zhang XZ, Gan YR, Zhao FN. Determination of residual clenbuterol in pork meat and liver by HPLC with electrochemical detection. Yao Xue Xue Bao 39, 276-280 (2004).
89. Crescenzi C, Bayoudh S, Cormack PA, Klein T, Ensing K. Determination of clenbuterol in bovine liver by combining matrix solid-phase dispersion and molecular imprinted solid-phase extraction followed by liquid chromatography/electrospray ion trap multiple-stage mass spectrometry. Anal. Chem. 73, 2171-2177 (2001).
90. Bazylak G, Nagels LJ. Simultaneous high-throughput determination of clenbuterol, ambroxol and bromhexine in pharmaceutical formulations by HPLC with potentiometric detection. J. Pharm. Biomed. Anal. 32, 887-903 (2003).
91. Brambilla G, Fiori M, Rizzo B, Crescenzi V, Masci G. Use of molecularly imprinted polymers in the solid-phase extraction of clenbuterol from animal feeds and biological matrices. J. Chromatogr. B Biomed. Sci. Appl. 759, 27-32 (2001).
92. Blomgren A, Berggren C, Holmberg A, Larsson F, Sellergren B, Ensing K. Extraction of clenbuterol from calf urine using a molecularly imprinted polymer followed by quantitation by high-performance liquid chromatography with UV detection. J. Chromatogr. A 975, 157-164 (2002).
93. Hogendoorn EA, van Zoonen P, Polettini A, Montagna M. Hyphenation of coupled-column liquid chromatography and thermospray tandem mass spectrometry for the rapid determination of b2-agonist residues in bovine urine using direct large-volume sample injection. Set-up of single-residue methods for clenbuterol and salbutamol. J. Mass Spectrom. 31, 418-426 (1996).
94. Dickson LC, MacNeil JD, Lee S, Fesser AC. Determination of b-agonist residues in bovine urine using liquid chromatography-tandem mass spectrometry. J. AOAC Int. 88, 46-56 (2005).
95. Fesser AC, Dickson LC, MacNeil JD, Patterson JR, Lee S, Gedir R. Determination of b-agonists in liver and retina by liquid chromatography-tandem mass spectrometry. J. AOAC Int. 88, 61-69 (2005).
96. Widstrand C, Larsson F, Fiori M, Civitareale C, Mirante S, Brambilla G. Evaluation of MISPE for the multi-residue extraction of b-agonists from calves urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 804, 85-91 (2004).
97. Joyce C, Smyth WF, Ramachandran VN, O'Kane E, Coulter DJ. The characterisation of selected drugs with amine-containing side chains using electrospray ionisation and ion trap mass spectrometry and their determination by HPLC-ESI-MS. J. Pharm. Biomed. Anal. 36, 465-476 (2004).
98. van Hout MW, Hofand CM, Niederlander HA, de Jong GJ. On-line coupling of solid-phase extraction with mass spectrometry for the analysis of biological samples. II. Determination of clenbuterol in urine using multiple-stage mass spectrometry in an ion-trap mass spectrometer. Rapid Commun. Mass Spectrom. 14, 2103-2111 (2000).
99. van Hout M W, Niederlander HA, de Zeeuw RA, de Jong GJ. Ion suppression in the determination of clenbuterol in urine by solid-phase extraction atmospheric pressure chemical ionisation ion-trap mass spectrometry. Rapid Commun. Mass Spectrom. 17, 245-250 (2003).
100. Huang JF, Zhang HJ, Lin B, Yu QW, Feng YQ. Multiresidue analysis of b-agonists in pork by coupling polymer monolith microextraction to electrospray quadrupole time-of-fight mass spectrometry. Rapid Commun. Mass Spectrom. 21, 2895-2904 (2007).
101. Lin Z, Zhang S, Zhao M, Yang C, Chen D, Zhang X. Rapid screening of clenbuterol in urine samples by desorption electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 22, 1882-1888 (2008).
102. Shi Y, Huang Y, Duan J, Chen H, Chen G. Field-amplifed on-line sample stacking for separation and determination of cimaterol, clenbuterol and salbutamol using capillary electrophoresis. J. Chromatogr. A 1125, 124-128 (2006).
103. Sirichai S, Khanatharana P. Rapid analysis of clenbuterol, salbutamol, procaterol, and fenoterol in pharmaceuticals and human urine by capillary electrophoresis. Talanta 76, 1194-1198 (2008).
104. Zhou S, Wang Y, De Beer T et al. Simultaneous separation of eight b-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresis. Electrophoresis 29, 2321-2329 (2008).
105. Chen Q, Fan LY, Zhang W, Cao CX. Separation and determination of abused drugs clenbuterol and salbutamol from complex extractants in swine feed by capillary zone electrophoresis with simple pretreatment. Talanta 76, 282-287 (2008).
106. Vela J, Yanes EG, Stalcup AM. Quantitative determination of clenbuterol, salbutamol and tulobuterol enantiomers by capillary electrophoresis. Fresenius J. Anal. Chem. 369, 212-219 (2001).
107. Kim KH, Kim HJ, Jeun EY et al. Chiral separation of b2-agonists by capillary electrophoresis using hydroxypropyl-a-cyclodextrin as a chiral selector. Arch. Pharm. Res. 24, 281-285 (2001).
108. Toussaint B, Hubert PH, Tjaden UR, van der Greef J, Crommen J. Enantiomeric separation of clenbuterol by transient isotachophoresis-capillary zone electrophoresis-UV detection new optimization technique for transient isotachophoresis. J. Chromatogr. A 871, 173-180 (2000).
109. Anurukvorakun O, Suntornsuk W, Suntornsuk L. Factorial design applied to a non-aqueous capillary electrophoresis method for the separation of b-agonists. J. Chromatogr. A 1134, 326-332 (2006).
110. Garcia-Ruiz C, Marina ML. Fast enantiomeric separation of basis drugs by electrokinetic chromatography. Application to the quantitation of terbutaline in a pharmaceutical preparation. Electrophoresis 22, 3191-3197 (2001).
111. Toussaint B, Palmer M, Chiap P, Hubert P, Crommen J. On-line coupling of partial flling-capillary zone electrophoresis with mass spectrometry for the separation of clenbuterol enantiomers. Electrophoresis 22, 1363-1372 (2001).
112. Huikko K, Kotiaho T, Kostiainen R. Effects of nebulizing and drying gas fow on capillary electrophoresis/mass spectrometry. Rapid Commun. Mass Spectrom. 16, 1562-1568 (2002).
113. Zhou J, Xu X, Wang Y. Competitive immunoassay for clenbuterol using capillary electrophoresis with laser-induced fuorescence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 848, 226-231 (2007).
114. Berggren C, Bayoudh S, Sherrington D, Ensing K. Use of molecularly imprinted solid-phase extraction for the selective clean-up of clenbuterol from calf urine. J. Chromatogr. A 889, 105-110 (2000).
115. Koster EH, Crescenzi C, den Hoedt W, Ensing K, de Jong GJ. Fibers coated with molecularly imprinted polymers for solid-phase microextraction. Anal. Chem. 73, 3140-3145 (2001).
116. Katz SE, Siewierski M. Drug residue analysis using immunoaffnity chromatography. J. Chromatogr. 624, 403-409 (1992).
117. Geyer H, Mareck-Engelke U, Schänzer W, Donike M. Simple purifcation of urine samples for improved detection of anabolic and endogenous steroids. In: Recent Advances in Doping Analysis. Donike M, Geyer H, Gotzmann A, Mareck-Engelke U, Rauth S (Eds). Sport und Buch Strauss, Köln, Germany, 97-104 (1994).
118. Silva AI Jr, Pereira HM, Casilli A, Aquino Neto FR. Analytical challenges in doping control: GCxGC: is it an option? In: Recent Advances in Doping Analysis. Schänzer W, Geyer H, Gotzmann A, Mareck U (Eds). Sport und Buch Strauß, Köln, Germany, 217-226 (2007).
119. Silva AI Jr, Pereira HM, Casilli A, Conceicao FC, Aquino Neto FR. Analytical challenges in doping control: comprehensive two-dimensional gas chromatography with time of fight mass spectrometry, a promising option. J. Chromatogr. A 1216(14), 2913-2922 (2008).
120. Fiori M, Cartoni C, Bocca B, Brambilla G. The use of nonendcapped C18 columns in the cleanup of clenbuterol and a new adrenergic agonist from bovine liver by gas chromatography-tandem mass spectrometry analysis. J. Chromatogr. Sci. 40, 92-96 (2002).
121. Lai WH, Fung DY, Xu Y, Xiong YH. Screening procedures for clenbuterol residue determination in raw swine livers using lateral-fow assay and enzyme-linked immunosorbent assay. J. Food Prot. 71, 865-869 (2008).
122. Lin LA, Tomlinson JA, Satzger RD. Detection of clenbuterol in bovine retinal tissue by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. A 762, 275-280 (1997).
123. Pfaff MW, van Ginkel LA, McEvoy JD, Maghuin-Rogister G, Meyer HH. Development of clenbuterol reference materials: lyophilized bovine eye samples free of clenbuterol (CRM 673) and containing clenbuterol (CRM 674). Part 1. Preparation, homogeneity and stability. Fresenius J. Anal. Chem. 371, 1086-1091 (2001).
124. Gaillard Y, Pepin G. Testing hair for pharmaceuticals. J. Chromatogr. B Biomed. Sci. Appl. 733, 231-246 (1999).
125. Blank DL, Kidwell DA. Decontamination procedures for drugs of abuse in hair: are they suffcient? Forensic Sci. Int. 70, 13-38 (1995).
126. Gleixner A, Sauerwein H, Meyer HH. Probenecid, sulfnpyrazone and pyrazinamide do not inhibit urinary excretion of the b2-adrenoceptor agonist clenbuterol in cattle. Food Addit. Contam. 13, 603-608 (1996).
127. Hernandez-Carrasquilla M. External contamination of bovine hair with b2-agonist compounds: evaluation of decontamination strategies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 767, 235-243 (2002).
128. Deng XS, Kurosu A, Pounder DJ. Detection of anabolic steroids in head hair. J. Forensic Sci. 44, 343-346 (1999).
129. Melwanki MB, Fuh MR. Dispersive liquid-liquid microextraction combined with semi-automated in-syringe back extraction as a new approach for the sample preparation of ionizable organic compounds prior to liquid chromatography. J. Chromatogr. A 1198-1199, 1-6 (2008).
130. Mayr A. Illegal antibiotics and hormones in swine raising. Is the meat a health risk? MMW Fortschr. Med. 143, 16 (2001).
131. Paige C. The issues of residues and human health. J. Am. Vet. Med. Assoc. 213, 1735-1736 (1998).
132. Polettini A, Ricossa MC, Groppi A, Montagna M. Determination of clenbuterol in urine as its cyclic boronate derivative by gas chromatography-mass spectrometry. J. Chromatogr. 564, 529-535 (1991).
133. Kintz P, Dumestre-Toulet V, Jamey C, Cirimele V, Ludes B. Doping control for b-adrenergic compounds through hair analysis. J. Forensic Sci. 45, 170-174 (2000).